Author： Zidek W. Tepel M. Schluter H. van der Giet M. Jankowski J.
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.2, Iss.1, 1998-07, pp. : 101-103
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
No requirement of P2X1 purinoceptors for platelet aggregation
By Takano S. Kimura J. Matsuoka I. Ono T.
European Journal of Pharmacology, Vol. 372, Iss. 3, 1999-05 ,pp. :
Access to resources
Recommend
How should P 2X purinoceptors be classified pharmacologically?
Trends in Pharmacological Sciences, Vol. 16, Iss. 5, 1995-05 ,pp. :
By Ziganshin A.U. Berdnikov E.A. Ziganshina L.E. Tantasheva F.R. Hoyle C.H.V. Burnstock G.
General Pharmacology, Vol. 26, Iss. 3, 1995-05 ,pp. :